Adma Biologics reported 15.02 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Adma Biologics 15.02 14.71 Mar/2026
Alnylam Pharmaceuticals 80.04 90.66 Mar/2026
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
Novavax 2.01 1.07 Dec/2025
Takeda 46.52 188.53 Mar/2026